Dr. Ryan Dellamaggiora, MD

Dr. Dellamaggiora practices at Tower Outpatient Surgery Center in Los Angeles, California.

Dr. Dellamaggiora's NPI, 1548463250, was assigned on June 8, 2007. Dr. Dellamaggiora graduated from Keck School of Medicine of USC in 2005. Dr. Dellamaggiora holds California license A100387.

Dr. Dellamaggiora's primary practice is Tower Outpatient Surgery Center, at 8635 W 3rd St, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 659-9408.

Dr. Dellamaggiora's primary practice is Tower Outpatient Surgery Center in Los Angeles, California. Dr. Dellamaggiora is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Dellamaggiora to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellamaggiora practices, 3 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Dellamaggiora's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Dellamaggiora is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Dellamaggiora is licensed in California.

Dmand AI lists arm, wrist, hand fracture and dislocation, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint cyst and minor injury to a limb among the conditions Dr. Dellamaggiora treats.

CMS data shows 3,436 Medicare services from Dr. Dellamaggiora across 22 procedure codes in 2024, for 906 Medicare patients. Medicare paid $242,340 for them.

CMS counts 906 Medicare patients who saw Dr. Dellamaggiora in 2024. The largest group is 65 to 74, with 400 patients. 75% of them have arthritis, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dellamaggiora's median patient age at 65, with 58% women.

In 2024, Dr. Dellamaggiora wrote 41 Medicare Part D claims for 37 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $101 in total drug cost. In 2022, CMS named 69 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dellamaggiora for performance year 2024, reported as part of a group. Dr. Dellamaggiora accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dellamaggiora as offering telehealth. CMS counts 119 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Dellamaggiora, more than 97% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 183 general payments to Dr. Dellamaggiora from 21 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Endo USA, Inc. paid the most, $27,040.

Dmand AI lists 1 award for Dr. Dellamaggiora, most recently CMS Stage 1 EHR in 2013.

Dr. Dellamaggiora graduated from Keck School of Medicine of USC in 2005.

Dr. Dellamaggiora is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.